02 Nov2013
Pill-Sized Implant Enters Clinical Trials as Vaccine Against Deadly Cancer
A promising new approach to treating cancer involves removing some of the patient’s immune T cells and reprogramming them so that they can successfully destroy cancer cells. The modified cells are cultivated in the lab before being re-introduced into the patient to grow their ranks and kill off cancer.
A new study that was conducted in Boston, US, has found that the Y chromosome in men increases risks to prostate cancer. Dr Lisa Cannon-Albright, professor and chief of the division of genetic epidemiology at the University of Utah School of Medicine, US, who is also the study leader presented the results at the research presented at the American Society of Human Genetics meeting.